Germany
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
20.96%
|
Dec. 31, 2023 | USD 42.00 | -2.04% |
|
Germany |
|
2 |
18.08%
|
Dec. 31, 2023 | USD 121.26 | -1.11% |
|
Germany |
|
3 |
-0.47%
|
Dec. 31, 2023 | USD 54.35 | -2.09% |
|
Germany |
|
4 |
-164.49%
|
Dec. 31, 2023 | USD 1.41 | -2.04% |
|
Germany |
|
5 |
-215.13%
|
Nov. 30, 2023 | USD 2.38 | -3.93% |
|
Germany |
|
6 |
-510.08%
|
Dec. 31, 2023 | USD 3.51 | -6.11% |
|
Germany |
|
7 |
-71,182.13%
|
Dec. 31, 2023 | USD 2.41 | 1.69% |
|
Germany |
The Vaccines company in Germany with the highest Operating Income Margin is Biotest AG (XETRA: BIO.DE) at 20.96%.
The Vaccines company in Germany with the lowest Operating Income Margin is InflaRx N.V. (NasdaqGS: IFRX) at -71,182.13%.
The top 10 Vaccines companies in Germany by Operating Income Margin are Biotest AG, BioNTech SE, Formycon AG, NanoRepro AG, Heidelberg Pharma AG, CureVac N.V. and InflaRx N.V..
The bottom 10 Vaccines companies in Germany by Operating Income Margin are InflaRx N.V., CureVac N.V., Heidelberg Pharma AG, NanoRepro AG, Formycon AG, BioNTech SE and Biotest AG.